EPISODE · Apr 24, 2026 · 12 MIN
PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗?(Chinese-language podcast)
from Citeline Podcasts · host Norstella
本期《中国生物技术播客》聚焦康方生物的依沃西单抗将如何改写历史,以及在PD-(L)1/VEGF双抗之间是否即将发生国内头对头三期临床试验。 Could PD-(L)1/VEGF Agents Face Off First In China Phase III Trials?
Embed this episode
Ready to play
PD-(L)1/VEGF双抗赛道——中国可否率先改写一线肺癌标准治疗?(Chinese-language podcast)
0:00
12:22
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
Frequently Asked Questions
How long is this episode of Citeline Podcasts?
This episode is 12 minutes long.
When was this Citeline Podcasts episode published?
This episode was published on April 24, 2026.
Can I download this Citeline Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!